Imugene Limited (IMU.AX)
AUD 0.02
(-4.17%)
AUD 0.02
(-4.17%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -149.68 Million AUD | -294.78% |
| 2023 | -37.91 Million AUD | -0.12% |
| 2022 | -37.86 Million AUD | -105.19% |
| 2021 | -18.45 Million AUD | -75.63% |
| 2020 | -10.5 Million AUD | -35.14% |
| 2019 | -7.77 Million AUD | -97.66% |
| 2018 | -3.93 Million AUD | -56.93% |
| 2017 | -2.5 Million AUD | 8.21% |
| 2016 | -2.73 Million AUD | -11.88% |
| 2015 | -2.44 Million AUD | -15.35% |
| 2014 | -2.11 Million AUD | -35.68% |
| 2013 | -1.55 Million AUD | 50.23% |
| 2012 | -3.13 Million AUD | -854.06% |
| 2011 | 415.53 Thousand AUD | 127.07% |
| 2010 | -1.53 Million AUD | -336.06% |
| 2009 | 650.28 Thousand AUD | 134.03% |
| 2008 | -1.91 Million AUD | 17.07% |
| 2007 | -2.3 Million AUD | -5.35% |
| 2006 | -2.18 Million AUD | -21.9% |
| 2005 | -1.79 Million AUD | 15.19% |
| 2004 | -2.11 Million AUD | -402.65% |
| 2003 | 699.06 Thousand AUD | 189.39% |
| 2002 | -782 Thousand AUD | 80.65% |
| 2001 | -4.04 Million AUD | 8.54% |
| 2000 | -4.41 Million AUD | 10.37% |
| 1999 | -4.93 Million AUD | -8.45% |
| 1998 | -4.54 Million AUD | -108.34% |
| 1997 | -2.18 Million AUD | 48.59% |
| 1996 | -4.24 Million AUD | -98.78% |
| 1995 | -2.13 Million AUD | -144.0% |
| 1994 | -875 Thousand AUD | -460.08% |
| 1993 | 243 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -80.96 Million AUD | 0.0% |
| 2024 FY | -149.68 Million AUD | -294.78% |
| 2024 Q2 | -68.71 Million AUD | 0.0% |
| 2023 FY | -37.91 Million AUD | -0.12% |
| 2023 Q4 | -20.52 Million AUD | 0.0% |
| 2023 Q2 | -17.39 Million AUD | 0.0% |
| 2022 Q4 | -23.03 Million AUD | 0.0% |
| 2022 FY | -37.86 Million AUD | -105.19% |
| 2022 Q2 | -14.83 Million AUD | 0.0% |
| 2021 FY | -18.45 Million AUD | -75.63% |
| 2021 Q2 | -6.06 Million AUD | 0.0% |
| 2021 Q4 | -12.39 Million AUD | 0.0% |
| 2020 Q2 | -4.79 Million AUD | 0.0% |
| 2020 FY | -10.5 Million AUD | -35.14% |
| 2020 Q4 | -5.71 Million AUD | 0.0% |
| 2019 Q2 | -3.44 Million AUD | 0.0% |
| 2019 FY | -7.77 Million AUD | -97.66% |
| 2019 Q4 | -4.32 Million AUD | 0.0% |
| 2018 Q2 | -1.63 Million AUD | 0.0% |
| 2018 FY | -3.93 Million AUD | -56.93% |
| 2018 Q4 | -2.3 Million AUD | 0.0% |
| 2017 Q2 | -1.49 Million AUD | 0.0% |
| 2017 FY | -2.5 Million AUD | 8.21% |
| 2017 Q4 | -1.01 Million AUD | 0.0% |
| 2016 FY | -2.73 Million AUD | -11.88% |
| 2016 Q4 | -1.69 Million AUD | 0.0% |
| 2016 Q2 | -1.03 Million AUD | 0.0% |
| 2015 Q2 | -1.05 Million AUD | 0.0% |
| 2015 FY | -2.44 Million AUD | -15.35% |
| 2015 Q4 | -1.38 Million AUD | 0.0% |
| 2014 Q2 | -1.51 Million AUD | 0.0% |
| 2014 FY | -2.11 Million AUD | -35.68% |
| 2014 Q4 | -603.88 Thousand AUD | 0.0% |
| 2013 Q3 | -389.89 Thousand AUD | 68.46% |
| 2013 Q4 | -323.56 Thousand AUD | 17.01% |
| 2013 Q2 | -1.23 Million AUD | -57.78% |
| 2013 Q1 | -783.35 Thousand AUD | 0.0% |
| 2013 FY | -1.55 Million AUD | 50.23% |
| 2012 FY | -3.13 Million AUD | -854.06% |
| 2012 Q4 | -783.35 Thousand AUD | 0.0% |
| 2012 Q3 | -783.35 Thousand AUD | 0.0% |
| 2012 Q2 | -783.35 Thousand AUD | -854.07% |
| 2012 Q1 | 103.88 Thousand AUD | 0.0% |
| 2011 FY | 415.53 Thousand AUD | 127.07% |
| 2011 Q4 | 103.88 Thousand AUD | 0.0% |
| 2011 Q3 | 103.88 Thousand AUD | 0.0% |
| 2011 Q2 | 103.88 Thousand AUD | 127.07% |
| 2011 Q1 | -383.76 Thousand AUD | 0.0% |
| 2010 Q1 | 162.57 Thousand AUD | 0.0% |
| 2010 Q2 | -383.76 Thousand AUD | -336.06% |
| 2010 Q4 | -383.76 Thousand AUD | 0.0% |
| 2010 Q3 | -383.76 Thousand AUD | 0.0% |
| 2010 FY | -1.53 Million AUD | -336.06% |
| 2009 Q2 | 162.57 Thousand AUD | 134.03% |
| 2009 Q4 | 162.57 Thousand AUD | 0.0% |
| 2009 Q3 | 162.57 Thousand AUD | 0.0% |
| 2009 FY | 650.28 Thousand AUD | 134.03% |
| 2009 Q1 | -477.73 Thousand AUD | 0.0% |
| 2008 Q1 | -576.06 Thousand AUD | 0.0% |
| 2008 FY | -1.91 Million AUD | 17.07% |
| 2008 Q4 | -477.73 Thousand AUD | 0.0% |
| 2008 Q3 | -477.73 Thousand AUD | 0.0% |
| 2008 Q2 | -477.73 Thousand AUD | 17.07% |
| 2007 Q2 | -576.06 Thousand AUD | -5.35% |
| 2007 Q4 | -576.06 Thousand AUD | 0.0% |
| 2007 FY | -2.3 Million AUD | -5.35% |
| 2007 Q1 | -546.8 Thousand AUD | 0.0% |
| 2007 Q3 | -576.06 Thousand AUD | 0.0% |
| 2006 Q3 | -546.8 Thousand AUD | 0.0% |
| 2006 FY | -2.18 Million AUD | -21.9% |
| 2006 Q4 | -546.8 Thousand AUD | 0.0% |
| 2006 Q2 | -546.8 Thousand AUD | -21.9% |
| 2006 Q1 | -448.55 Thousand AUD | 0.0% |
| 2005 FY | -1.79 Million AUD | 15.19% |
| 2005 Q4 | -448.55 Thousand AUD | 0.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q3 | -448.55 Thousand AUD | 0.0% |
| 2005 Q2 | -448.55 Thousand AUD | 0.0% |
| 2004 FY | -2.11 Million AUD | -402.65% |
| 2004 Q3 | - AUD | 0.0% |
| 2004 Q2 | - AUD | -100.0% |
| 2004 Q1 | 174.76 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2003 Q4 | 174.76 Thousand AUD | 0.0% |
| 2003 FY | 699.06 Thousand AUD | 189.39% |
| 2003 Q3 | 174.76 Thousand AUD | 0.0% |
| 2003 Q1 | -195.59 Thousand AUD | 0.0% |
| 2003 Q2 | 174.76 Thousand AUD | 189.35% |
| 2002 Q1 | -1.01 Million AUD | 0.0% |
| 2002 Q3 | -195.59 Thousand AUD | 0.0% |
| 2002 FY | -782 Thousand AUD | 80.65% |
| 2002 Q2 | -195.59 Thousand AUD | 80.64% |
| 2002 Q4 | -195.59 Thousand AUD | 0.0% |
| 2001 Q1 | -1.1 Million AUD | 0.0% |
| 2001 Q3 | -1.01 Million AUD | 0.0% |
| 2001 Q4 | -1.01 Million AUD | 0.0% |
| 2001 FY | -4.04 Million AUD | 8.54% |
| 2001 Q2 | -1.01 Million AUD | 8.55% |
| 2000 Q2 | -1.1 Million AUD | 10.36% |
| 2000 Q4 | -1.1 Million AUD | 0.0% |
| 2000 Q3 | -1.1 Million AUD | 0.0% |
| 2000 FY | -4.41 Million AUD | 10.37% |
| 2000 Q1 | -1.23 Million AUD | 0.0% |
| 1999 Q4 | -1.23 Million AUD | 0.0% |
| 1999 Q2 | -1.23 Million AUD | -8.45% |
| 1999 Q3 | -1.23 Million AUD | 0.0% |
| 1999 Q1 | -1.13 Million AUD | 0.0% |
| 1999 FY | -4.93 Million AUD | -8.45% |
| 1998 Q2 | -1.13 Million AUD | -108.34% |
| 1998 Q3 | -1.13 Million AUD | 0.0% |
| 1998 Q1 | -545.5 Thousand AUD | 0.0% |
| 1998 Q4 | -1.13 Million AUD | 0.0% |
| 1998 FY | -4.54 Million AUD | -108.34% |
| 1997 Q3 | -545.5 Thousand AUD | 0.0% |
| 1997 FY | -2.18 Million AUD | 48.59% |
| 1997 Q4 | -545.5 Thousand AUD | 0.0% |
| 1997 Q2 | -545.5 Thousand AUD | 48.59% |
| 1997 Q1 | -1.06 Million AUD | 0.0% |
| 1996 Q4 | -1.06 Million AUD | 0.0% |
| 1996 Q3 | -1.06 Million AUD | 0.0% |
| 1996 FY | -4.24 Million AUD | -98.78% |
| 1996 Q2 | -1.06 Million AUD | -98.78% |
| 1996 Q1 | -533.75 Thousand AUD | 0.0% |
| 1995 FY | -2.13 Million AUD | -144.0% |
| 1995 Q1 | -218.75 Thousand AUD | 0.0% |
| 1995 Q2 | -533.75 Thousand AUD | -144.0% |
| 1995 Q3 | -533.75 Thousand AUD | 0.0% |
| 1995 Q4 | -533.75 Thousand AUD | 0.0% |
| 1994 Q4 | -218.75 Thousand AUD | 0.0% |
| 1994 Q2 | -218.75 Thousand AUD | -460.08% |
| 1994 Q3 | -218.75 Thousand AUD | 0.0% |
| 1994 FY | -875 Thousand AUD | -460.08% |
| 1994 Q1 | 60.75 Thousand AUD | 0.0% |
| 1993 Q4 | 60.75 Thousand AUD | 0.0% |
| 1993 FY | 243 Thousand AUD | 0.0% |
| 1993 Q2 | 60.75 Thousand AUD | 0.0% |
| 1993 Q3 | 60.75 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | -2681.51% |
| Acrux Limited | -5.8 Million AUD | -2480.699% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -3223.684% |
| Biome Australia Limited | -1.67 Million AUD | -8861.823% |
| BTC Health Limited | 1.05 Million AUD | 14283.87% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | -1094.592% |
| CSL Limited | 2.64 Billion AUD | 105.665% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | -253.65% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 520.022% |
| Noxopharm Limited | -3.57 Million AUD | -4083.221% |
| PharmAust Limited | -9.03 Million AUD | -1557.159% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -2247.481% |
| Prescient Therapeutics Limited | -8.23 Million AUD | -1716.942% |
| PYC Therapeutics Limited | -37.72 Million AUD | -296.763% |
| Race Oncology Limited | -13.81 Million AUD | -983.124% |
| Starpharma Holdings Limited | -8.16 Million AUD | -1733.197% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 2249.197% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | -979.19% |
| Memphasys Limited | -4.44 Million AUD | -3269.65% |
| Nyrada Inc. | -1.38 Million AUD | -10697.693% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -10213.961% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 2972.396% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -6112.927% |
| Zelira Therapeutics Limited | -36.56 Million AUD | -309.311% |
| Patrys Limited | -3.53 Million AUD | -4129.279% |
| Dimerix Limited | -17.07 Million AUD | -776.602% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 195.289% |
| Orthocell Limited | -7.18 Million AUD | -1984.409% |
| Cynata Therapeutics Limited | -9.74 Million AUD | -1436.019% |
| Immutep Limited | -39.89 Million AUD | -275.174% |
| Arovella Therapeutics Limited | -8.74 Million AUD | -1611.41% |
| Alterity Therapeutics Limited | -19.12 Million AUD | -682.706% |
| Nanollose Limited | -1.15 Million AUD | -12841.952% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -9016.806% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 46267.774% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -5125.696% |
| Biotron Limited | -3.43 Million AUD | -4255.58% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | -212.165% |
| Tissue Repair Ltd | -4.13 Million AUD | -3517.128% |
| AnteoTech Limited | -8.88 Million AUD | -1585.494% |
| Hexima Limited | -933.87 Thousand AUD | -15927.933% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | -155.196% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | -747.486% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -4255.533% |
| Actinogen Medical Limited | -13.04 Million AUD | -1047.48% |
| Immuron Limited | -6.93 Million AUD | -2057.726% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -2631.652% |